Status:
COMPLETED
Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Prostate Cancer
Kidney Cancer
Eligibility:
All Genders
18+ years
Brief Summary
In France, the second cancer plan of 2009-2013 aimed to strengthen the role of MT by putting it back at the center of patient monitoring, in particular by asking "regional health agencies to encourage...
Eligibility Criteria
Inclusion
- Adult subjects (≥18 years old)
- Patient operated on for localized prostate or kidney cancer
- Patient followed at the HUS during the period from 01/01/2015 to 12/31/2021
- Subject who has not expressed his opposition, after information, to the reuse of his data for the purposes of this research.
Exclusion
- Subject having expressed opposition to participating in the study
- Patient under active therapy (hormonotherapy, systemic treatment) for the pathology studied
- Impossibility of providing the subject with informed information (difficulties in understanding the subject, etc.)
- Subject under judicial protection
- Subjects under guardianship or curatorship
Key Trial Info
Start Date :
December 20 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 21 2022
Estimated Enrollment :
178 Patients enrolled
Trial Details
Trial ID
NCT06214000
Start Date
December 20 2021
End Date
June 21 2022
Last Update
March 13 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service d'Urologie - CHU de Strasbourg - France
Strasbourg, France, 67091